investorscraft@gmail.com

Intrinsic ValueReinsurance Group of America, Incorporated (RGA)

Previous Close$192.20
Intrinsic Value
Upside potential
Previous Close
$192.20

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Reinsurance Group of America, Incorporated (RGA) operates as a global leader in the reinsurance industry, specializing in life and health reinsurance solutions. The company generates revenue primarily through risk-sharing agreements with insurers, offering products such as longevity reinsurance, disability coverage, and critical illness protection. RGA’s diversified portfolio spans North America, Asia-Pacific, Europe, and other regions, positioning it as a key player in mitigating insurers’ exposure to mortality and morbidity risks. The firm’s deep actuarial expertise and strong underwriting discipline enable it to maintain a competitive edge in a complex, highly regulated market. RGA’s market position is reinforced by long-standing relationships with primary insurers and its ability to structure tailored reinsurance treaties. The company’s focus on innovation, including data analytics and predictive modeling, further enhances its value proposition in an industry increasingly driven by technological advancements.

Revenue Profitability And Efficiency

RGA reported revenue of $21.995 billion for FY 2024, with net income of $717 million, reflecting a net margin of approximately 3.3%. Diluted EPS stood at $10.73, indicating stable earnings per share performance. Operating cash flow was robust at $9.37 billion, underscoring the company’s ability to generate liquidity from core operations. Notably, RGA’s capital expenditures were negligible, highlighting its asset-light business model and operational efficiency.

Earnings Power And Capital Efficiency

The company’s earnings power is driven by its underwriting discipline and investment income, with a focus on long-term profitability. RGA’s capital efficiency is evident in its ability to deploy reinsurance capacity effectively across global markets. The firm’s diluted EPS of $10.73 demonstrates its capacity to deliver consistent shareholder returns, supported by a balanced approach to risk management and capital allocation.

Balance Sheet And Financial Health

RGA maintains a solid balance sheet, with cash and equivalents of $3.326 billion and total debt of $5.042 billion. The company’s financial health is supported by strong operating cash flows, which provide ample liquidity to meet obligations. The debt level is manageable relative to its cash reserves and earnings capacity, reflecting a prudent approach to leverage.

Growth Trends And Dividend Policy

RGA has demonstrated steady growth in its reinsurance portfolio, with a focus on expanding its presence in emerging markets. The company’s dividend policy is shareholder-friendly, with a dividend per share of $3.56, offering a yield that aligns with industry peers. This reflects RGA’s commitment to returning capital to shareholders while maintaining financial flexibility for strategic initiatives.

Valuation And Market Expectations

RGA’s valuation reflects its position as a leading reinsurer, with market expectations centered on its ability to sustain underwriting profitability and manage risks effectively. The company’s P/E ratio and other valuation metrics are likely influenced by its stable earnings and growth prospects in key markets. Investor sentiment is tempered by the inherent volatility of the reinsurance industry.

Strategic Advantages And Outlook

RGA’s strategic advantages include its global footprint, actuarial expertise, and strong client relationships. The outlook for the company is positive, driven by demand for reinsurance solutions in an aging population and increasing healthcare costs. However, macroeconomic uncertainties and regulatory changes remain key risks. RGA is well-positioned to navigate these challenges through its disciplined underwriting and innovative product offerings.

Sources

Company filings, investor presentations

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount